CreditReports.dk
HomeScreen companies

VAR2 PHARMACEUTICALS ApS Financials, key figures and credit report

CVR number: 34621942 Established 2012 Industry: 72 Scientific research and development
Company contact details
Nordre Fasanvej 215, 2000 Frederiksberg
Gross profit -21 739.0 kDKK FY 2025 +4.2% vs 2024
EBIT -26 352.2 kDKK FY 2025 +7.7% vs 2024
Net debt -48 031.9 kDKK FY 2025 -17.4% vs 2024
Quick ratio 23.6 FY 2025 -11 vs 2024

Income statement (kDKK)

2021
2022
2023
2024
2025
Fiscal period length1212121212
Net sales
Gross profit-4 433.18-6 358.28-22 299.60-22 697.87-21 739.01
Employee benefit expenses-3 119.12-2 788.60-3 274.11-5 859.20-4 613.24
EBIT-7 552.30-9 146.88-25 573.71-28 557.07-26 352.25
Other financial income284.71388.501 562.002 370.102 348.21
Other financial expenses- 206.07- 229.30-16.95-42.89- 359.00
Pre-tax profit-7 473.66-8 987.68-24 028.65-26 229.86-24 363.04
Income taxes1 568.692 182.534 909.685 223.854 636.53
Net earnings-5 904.97-6 805.16-19 118.98-21 006.01-19 726.51

Assets (kDKK)

2021
2022
2023
2024
2025
Intangible assets total
Tangible assets total
Holdings in group member companies45.0045.0045.0045.0045.00
Investments total58.1358.3948.5245.0045.00
Non-curr. owed by group member comp.6 038.36
Long term receivables total6 038.36
Inventories total
Current trade debtors44.26165.96376.2621.84
Current amounts owed by group member comp.8 990.5511 498.3717 251.1523 069.1329 821.49
Prepayments and accrued income20.8229.21498.07333.4299.50
Current other receivables45.57145.28245.711 924.121 680.68
Short term receivables total9 101.2111 838.8118 371.1825 326.6731 623.51
Cash and bank deposits29 301.4758 271.2840 924.9741 330.4248 031.88
Cash and cash equivalents29 301.4758 271.2840 924.9741 330.4248 031.88
Balance sheet total (assets)38 460.8170 168.4859 344.6766 702.0985 738.76

Equity and liabilities (kDKK)

2021
2022
2023
2024
2025
Share capital100.92105.28105.28109.64118.48
Retained earnings42 799.0774 085.2467 280.0985 352.25101 640.28
Profit of the financial year-5 904.97-6 805.16-19 118.98-21 006.01-19 726.51
Shareholders equity total36 995.0367 385.3748 266.4064 455.8882 032.25
Non-current other liabilities289.70
Non-current deferred tax liabilities289.70289.70319.18330.99
Non-current liabilities total289.70289.70289.70319.18330.99
Current loans from credit institutions5.67
Current trade creditors334.121 222.098 069.14995.192 854.69
Current owed to group member424.88
Other non-interest bearing current liabilities841.961 271.322 713.75506.96520.84
Current liabilities total1 176.072 493.4110 788.571 927.033 375.52
Balance sheet total (liabilities)38 460.8170 168.4859 344.6766 702.0985 738.76
Page generated